ArticlePharmacoEconomics2017

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis.

Erik Landfeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.